Blastic plasmacytoid dendritic-cell neoplasm (BPDCN) is an aggressive hematologic cancer that confers a predisposition to leukemic transformation and poor outcomes. 1 The exact incidence of BPDCN ...

PDC*line is a potent, scalable and versatile professional antigen-presenting-cell line with great potential for treating wide range of cancers March 03, 2020 02:00 AM Eastern Standard Time ...

Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about ...

About PDC*lung01. PDC*lung01 is a cell suspension of seven active agents, made of irradiated human Plasmacytoid Dendritic Cells (PDC*line), loaded with HLA-A*02:01-restricted peptides, ...

Beck, RC et al. (2020) Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation. Clinical cytometry. doi: /10.1002/cyto.b.21761 ...

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a type of blood cancer that affects immune system cells. It most often affects the skin but can also involve bone marrow and other cell types.